WDFY4, also referred to as WD Repeat and FYVE Domain-Containing Protein 4, is a protein whose detailed function and interactions within cellular systems are still under investigation. However, it is known that the WD repeat and FYVE domain are structural motifs that play pivotal roles in mediating protein-protein interactions and in intracellular trafficking, respectively. Proteins with these domains are often involved in processes such as vesicle transport, signal transduction, and transcription regulation. The presence of these domains in WDFY4 suggests that it might be intricately involved in coordinating cellular responses to different stimuli by facilitating specific protein interactions or aiding in the transport of molecules within the cell.
Given the importance of WDFY4 in cellular processes, WDFY4 Inhibitors are chemical compounds designed to target and modulate the function of WDFY4. By inhibiting the activity or interactions of WDFY4, these inhibitors allow researchers to dissect its role and significance within the cell. The design and development of these inhibitors aim to ensure specificity towards WDFY4, thereby reducing off-target effects that might confound experimental results. In essence, WDFY4 inhibitors serve as valuable tools for the scientific community, enabling a more nuanced understanding of the protein's function, its interaction partners, and the cellular pathways it influences. As research progresses, these inhibitors will continue to provide insights into the broader implications of WDFY4 in cellular homeostasis and response mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor which could influence phosphoinositide levels and thus, potentially modulate WDFY4's interaction with cellular membranes via its FYVE domain. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
It's a known inhibitor of autophagy. Given WDFY4's potential role in autophagy, this compound might influence its expression or activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A GTPase inhibitor affecting endocytosis. Could potentially influence WDFY4's membrane-associated functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an autophagy activator, it might influence pathways in which WDFY4 might be involved. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
This compound promotes autophagy degradation and may influence WDFY4 expression or activity due to its potential role in autophagy. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that might modulate WDFY4's FYVE domain interactions by influencing phosphoinositide levels. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
An inhibitor of autophagy known to prevent autophagosome-lysosome fusion. Might influence WDFY4 expression or activity. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
This autophagy inhibitor could potentially modulate WDFY4's function or expression in the autophagy process. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
Another Vps34 inhibitor which might influence WDFY4's expression or activity in the context of autophagy. | ||||||